Dr. Michael Brandler, M.D

NPI: 1790737740
Total Payments
$966.15
2024 Payments
$73.70
Companies
7
Transactions
12

Payment Breakdown by Category

Food & Beverage$820.20 (84.9%)
Gifts$80.00 (8.3%)
Education$65.95 (6.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $820.20 10 84.9%
Gift $80.00 1 8.3%
Education $65.95 1 6.8%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $192.48 2 $0 (2018)
PFIZER INC. $162.46 2 $0 (2024)
Chiesi USA, Inc. $145.95 2 $0 (2022)
SOBI, INC $130.58 3 $0 (2023)
Mallinckrodt LLC $120.98 1 $0 (2018)
Shire North American Group Inc $118.73 1 $0 (2019)
Rhythm Pharmaceuticals, Inc. $94.97 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $73.70 1 PFIZER INC. ($73.70)
2023 $44.41 2 SOBI, INC ($44.41)
2022 $80.00 1 Chiesi USA, Inc. ($80.00)
2021 $94.97 1 Rhythm Pharmaceuticals, Inc. ($94.97)
2019 $204.90 2 Shire North American Group Inc ($118.73)
2018 $402.22 4 GlaxoSmithKline, LLC. ($192.48)
2017 $65.95 1 Chiesi USA, Inc. ($65.95)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/10/2024 PFIZER INC. PENBRAYA (Biological) Food and Beverage In-kind items and services $73.70 General
Category: VACCINES
09/20/2023 SOBI, INC Synagis (Drug) Food and Beverage In-kind items and services $29.42 General
Category: IMMUNOLOGY
01/30/2023 SOBI, INC Synagis (Drug) Food and Beverage In-kind items and services $14.99 General
Category: IMMUNOLOGY
11/10/2022 Chiesi USA, Inc. CUROSURF (Drug) Gift Cash or cash equivalent $80.00 General
Category: NEONATOLOGY
12/14/2021 Rhythm Pharmaceuticals, Inc. Food and Beverage In-kind items and services $94.97 General
04/28/2019 Sobi, Inc Synagis (Drug) Food and Beverage In-kind items and services $86.17 General
Category: Immunology
04/09/2019 Shire North American Group Inc VPRIV (Biological) Food and Beverage In-kind items and services $118.73 General
Category: GENETIC DISEASE
11/08/2018 GlaxoSmithKline, LLC. BEXSERO (Biological) Food and Beverage In-kind items and services $118.73 General
Category: VACCINES
10/09/2018 PFIZER INC. EUCRISA (Drug) Food and Beverage In-kind items and services $88.76 General
Category: DERMATOLOGY
06/08/2018 GlaxoSmithKline, LLC. BEXSERO (Biological) Food and Beverage In-kind items and services $73.75 General
Category: VACCINES
03/06/2018 Mallinckrodt LLC INOMAX (Drug) Food and Beverage In-kind items and services $120.98 General
Category: CRITICAL CARE
03/08/2017 Chiesi USA, Inc. CUROSURF (Drug) Education Cash or cash equivalent $65.95 General
Category: NEONATAL

About Dr. Michael Brandler, M.D

Dr. Michael Brandler, M.D is a Neonatal-Perinatal Medicine healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790737740.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Brandler, M.D has received a total of $966.15 in payments from pharmaceutical and medical device companies, with $73.70 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($820.20).

Practice Information

  • Specialty Neonatal-Perinatal Medicine
  • Location Flushing, NY
  • Active Since 05/17/2006
  • Last Updated 12/22/2022
  • Taxonomy Code 2080N0001X
  • Entity Type Individual
  • NPI Number 1790737740

Products in Payments

  • BEXSERO (Biological) $192.48
  • CUROSURF (Drug) $145.95
  • Synagis (Drug) $130.58
  • INOMAX (Drug) $120.98
  • VPRIV (Biological) $118.73
  • EUCRISA (Drug) $88.76
  • PENBRAYA (Biological) $73.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neonatal-Perinatal Medicine Doctors in Flushing